RT @davidbautistaqf: Haber tenido cóvid sintomática te da una protección del 70-90% contra cóvid grave en una reinfección, según este paper.
@Dt_Aerzteblatt https://t.co/IC7k9IxH24 https://t.co/pkC2yAMHO8 https://t.co/s5cV9r1rNk https://t.co/166kFRzug3 Bitte auch diesen Thread zur betreffenden Studie (+ den hier zitierten Thread) beachten: https://t.co/KMKZ964AwI 2/2
@robilad @markensysteme @CarstenWatzl Zum Beispiel diese hier:
RT @florian_krammer: @TheBinderLab @ewyler @Paul_Inger_ @Sander_Lab Hier eine Studie einer Kollegin die weiss, was sie tut (@AubreeGordonPh…
RT @florian_krammer: @TheBinderLab @ewyler @Paul_Inger_ @Sander_Lab Hier eine Studie einer Kollegin die weiss, was sie tut (@AubreeGordonPh…
RT @BlocknixBibi: @rudifussi Lassen Sie sich nicht desinformieren. Wenn man nur ältere Menschen mit vielen Vorerkrankungen (Medianalter 60)…
@rudifussi Lassen Sie sich nicht desinformieren. Wenn man nur ältere Menschen mit vielen Vorerkrankungen (Medianalter 60) und geschwächten Immunsystemen (alleine die häufigen Reinfektionen weisen darauf hin) untersucht, ist das das logische Ergebnis. Alle
RT @florian_krammer: @TheBinderLab @ewyler @Paul_Inger_ @Sander_Lab Hier eine Studie einer Kollegin die weiss, was sie tut (@AubreeGordonPh…
In dieser Studie schützt eine vorherige Infektion zu 80% vor mittlerem oder schwerem Verlauf. Noch ein Indiz, dass die Veteranen-Studie problematisch ist.
Trotz der beunruhigenden Ergebnissen des Preprints darf man nicht vergessen, dass vorige Studien zum Schluss kamen, dass das akute Risiko einer Re-Infx niedriger ist. Also bitte nicht gleich von 1 Studie verrückt machen lassen. 🙏 Danke @pelagicbird. https
RT florian_krammer https://t.co/3TdoDAByxq "TheBinderLab ewyler Paul_Inger_ Sander_Lab Hier eine Studie einer Kollegin die weiss, was sie tut (AubreeGordonPhD): https://t.co/eXAUOgxlj7"
@TheBinderLab @ewyler @Paul_Inger_ @Sander_Lab Hier eine Studie einer Kollegin die weiss, was sie tut (@AubreeGordonPhD): https://t.co/8LbqJ2QViw
RT @PGTimmune: @fitterhappierAJ @Anto_Berto Please provide citations! The ones I’m familiar with show some level of protection but perhaps…
@fitterhappierAJ @Anto_Berto Please provide citations! The ones I’m familiar with show some level of protection but perhaps less than we might have hoped. https://t.co/Mo97oftwnb
6/ Here's the link to this Nicaraguan study by Maier et al, based on n=2,353 (0-94 y), in 437 households. Almost all individuals were unvaccinated, so the analyses were not confounded by this (and also separately repeated without those few individuals). h
@aarnott Seems to be putting a lot of weight on a non-answer from a FOI request? CDC site regularly lists ongoing research. 12/3 update shows a couple preprints of studies from Nicaragua and Qatar on this topic. https://t.co/P9kRq97E1T https://t.co/UA2w
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
...but low vax rates e.g. Africa, E. Europe, parts of S. America where sig. proportions of the population were infected >1 year ago. Data for protection against sympt. and severe disease taken from : https://t.co/q2flCLoXQj https://t.co/oy6ZOxFJ3H h
@muscle96ss @TheAngryEpi @AZDHS And here's a new preprint with interesting data on effectiveness of previous infection at preventing reinfection: "An immune correlate of SARS-CoV-2 infection and severity of reinfections", https://t.co/vQ4twPpP6g
Preprint: "An immune correlate of SARS-CoV-2 infection and severity of reinfections": https://t.co/vQ4twPpP6g
RT @florian_krammer: Very nice paper about protection from reinfection in Nicaragua from @AubreeGordonPhD's group. Congrats Aubree, great w…
RT @hannahemaier: I sat down to tweet about our new preprint, but @florian_krammer beat me to it 😂. thank you! here's some more details…
@umichsph @AubreeGordonPhD and here's some more details on our findings: https://t.co/kIwr6a4Ayd
RT @hannahemaier: I sat down to tweet about our new preprint, but @florian_krammer beat me to it 😂. thank you! here's some more details…
The preprint “An immune correlate of SARS-CoV-2 infection and se…” (https://t.co/WviMzln88m) has been reviewed by automated tools, find results here: https://t.co/FkveBiZXQP. We detected 1 of 6 rigor criteria, 1 resource, and no limitations statement.
RT @florian_krammer: Very nice paper about protection from reinfection in Nicaragua from @AubreeGordonPhD's group. Congrats Aubree, great w…
RT @hannahemaier: I sat down to tweet about our new preprint, but @florian_krammer beat me to it 😂. thank you! here's some more details…
Estudio realizado en Nicaragua sobre la protección conferida por una infección previa por SARS-CoV-2, con datos muy reveladores del comportamiento de la pandemia y las variantes circulantes. https://t.co/enwEvZx0Gr
RT @florian_krammer: Very nice paper about protection from reinfection in Nicaragua from @AubreeGordonPhD's group. Congrats Aubree, great w…
RT @hannahemaier: I sat down to tweet about our new preprint, but @florian_krammer beat me to it 😂. thank you! here's some more details…
RT @hannahemaier: I sat down to tweet about our new preprint, but @florian_krammer beat me to it 😂. thank you! here's some more details…
There is what comes out of @RepThomasMassie's ass on the topic of "natural immunity" and then there is science ..
Data on COVID immunity from prior infection ..
RT @florian_krammer: Very nice paper about protection from reinfection in Nicaragua from @AubreeGordonPhD's group. Congrats Aubree, great w…
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
RT @hannahemaier: I sat down to tweet about our new preprint, but @florian_krammer beat me to it 😂. thank you! here's some more details…
@carignan_alex Addendum: voici un autre pre-print -à prendre avec des pincettes- qui tente d’établir un taux de nAbs vs protection/infection/severe. Il parle de 600 BAU. C’était donc minuit moins 5 pour ma blonde, chanceuse. Nous moins. Cordialement. C
RT @x2IndSpeculator: While waiting South African data, here's an interesting study of immune correlates vs. #SARS2 reinfection from Nicarag…
RT @davidbautistaqf: Haber tenido cóvid sintomática te da una protección del 70-90% contra cóvid grave en una reinfección, según este paper.
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
RT @hannahemaier: I sat down to tweet about our new preprint, but @florian_krammer beat me to it 😂. thank you! here's some more details…
RT @medrxivpreprint: An immune correlate of SARS-CoV-2 infection and severity of reinfections https://t.co/pP2AEyGQus #medRxiv
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
RT @florian_krammer: Very nice paper about protection from reinfection in Nicaragua from @AubreeGordonPhD's group. Congrats Aubree, great w…
RT @davidbautistaqf: Haber tenido cóvid sintomática te da una protección del 70-90% contra cóvid grave en una reinfección, según este paper.
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
RT @davidbautistaqf: Haber tenido cóvid sintomática te da una protección del 70-90% contra cóvid grave en una reinfección, según este paper.
Sero+ asso wth 69.2% protectn frm any infectn;higher protectn vs mod/severe infectn(79.4%);Anti-S titer 327/2,551 asso wth 50%/80% protect frm any infect;titers 284/656 suffic for protect vs mod/severe.2nd infect less severe;(RR) mod/severe:0.6;(RR)sub:1.9
RT @davidbautistaqf: Haber tenido cóvid sintomática te da una protección del 70-90% contra cóvid grave en una reinfección, según este paper.
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
RT @davidbautistaqf: Haber tenido cóvid sintomática te da una protección del 70-90% contra cóvid grave en una reinfección, según este paper.
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
RT @davidbautistaqf: Haber tenido cóvid sintomática te da una protección del 70-90% contra cóvid grave en una reinfección, según este paper.
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
Haber tenido cóvid sintomática te da una protección del 70-90% contra cóvid grave en una reinfección, según este paper.
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
RT @hannahemaier: I sat down to tweet about our new preprint, but @florian_krammer beat me to it 😂. thank you! here's some more details…
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
Jauns pre-prints (ne peer review). Pētnieki mēģināja noteikt a/v skaitu, kas būtu saistīts ar smagu slimību. Diemžēl, manuskripta ir vairākas neprecīzitātes, kas nedod izdarīt viennozīmīgus secinājumus: 1. Ļoti daudz pieņēmumu testos kāds a/v vai (1/) htt
RT @hannahemaier: I sat down to tweet about our new preprint, but @florian_krammer beat me to it 😂. thank you! here's some more details…
RT @hannahemaier: I sat down to tweet about our new preprint, but @florian_krammer beat me to it 😂. thank you! here's some more details…
This is a great study on reinfection risk
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
@mksgraz @florianaigner Ergänzende Studie h/t @florian_krammer: https://t.co/lX5WHEpDPJ
RT @florian_krammer: Very nice paper about protection from reinfection in Nicaragua from @AubreeGordonPhD's group. Congrats Aubree, great w…
RT @florian_krammer: Very nice paper about protection from reinfection in Nicaragua from @AubreeGordonPhD's group. Congrats Aubree, great w…
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
RT @pseudo_sapiens: This 👇🏻 For, those who are basing their arguments of not needing boosters because delta has caused natural infection &…
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
RT @florian_krammer: Very nice paper about protection from reinfection in Nicaragua from @AubreeGordonPhD's group. Congrats Aubree, great w…
Finally, a study that recognizes NI. Conclusions. Prior infection-induced immunity is protective against infection when predominantly gamma and delta SARS-CoV-2 circulated. https://t.co/b1cMHbwXJY
@zeynep this is pre-Delta expect worse outcomes with Delta https://t.co/RXxumiAGin
RT @pseudo_sapiens: This 👇🏻 For, those who are basing their arguments of not needing boosters because delta has caused natural infection &…
Conclusions. Prior infection-induced immunity is protective against infection when predominantly gamma and delta SARS-CoV-2 circulated. The protective antibody titers presented may be useful for vaccine policy and control measures. Great work.
This👇
RT @florian_krammer: Very nice paper about protection from reinfection in Nicaragua from @AubreeGordonPhD's group. Congrats Aubree, great w…
RT DanLarremore https://t.co/ah6PNTZX9b "RT hannahemaier: I sat down to tweet about our new preprint, but florian_krammer beat me to it 😂. thank you! here's some more details…"
RT @hannahemaier: I sat down to tweet about our new preprint, but @florian_krammer beat me to it 😂. thank you! here's some more details…
RT @florian_krammer: Very nice paper about protection from reinfection in Nicaragua from @AubreeGordonPhD's group. Congrats Aubree, great w…
RT @pseudo_sapiens: This 👇🏻 For, those who are basing their arguments of not needing boosters because delta has caused natural infection &…
RT @hannahemaier: I sat down to tweet about our new preprint, but @florian_krammer beat me to it 😂. thank you! here's some more details…
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
RT @hannahemaier: I sat down to tweet about our new preprint, but @florian_krammer beat me to it 😂. thank you! here's some more details…
RT @florian_krammer: Very nice paper about protection from reinfection in Nicaragua from @AubreeGordonPhD's group. Congrats Aubree, great w…
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
RT @florian_krammer: Very nice paper about protection from reinfection in Nicaragua from @AubreeGordonPhD's group. Congrats Aubree, great w…
RT @AubreeGordonPhD: Our new preprint natural infection induced SARS-CoV-2 immunity. We determine the level of protection when predominantl…
"Seropositivity was associated with 69.2% protection from any infection (95% CI: 60.7%-75.9%)." La inmunidad natural es una variable que habitualmente no siempre se considera al estimar protección poblacional. https://t.co/Cb7YJEJUn2
RT @hannahemaier: I sat down to tweet about our new preprint, but @florian_krammer beat me to it 😂. thank you! here's some more details…